named programs · 9 · from sources
What they call their work
Founding Underwriter for Development: Batch Production
Finances the manufacture of product batches for use in safety and performance testing.
Founding Underwriter for Development: Commercial Batch
Finances the production of the first commercial batch of the polymer therapy for affordable human use.
Founding Underwriter for Development: Molecule Engineering
Funds the final engineering of a polymer molecule designed to remove fluid equivalent to a dialysis session in a non-invasive, over-the-counter format.
Founding Underwriter for Development: Performance Validation (In Vivo)
Supports in vivo studies to confirm the polymer functions as intended in animal models under GLP regulations.
Founding Underwriter for Development: Performance Verification
Supports bench testing of the polymer material to confirm it meets specifications and performs as expected in vitro.
Founding Underwriter for Development: Safety and Performance Validation (Human Test: ESRD on Hemodialysis)
Funds clinical validation in end-stage renal disease patients currently on dialysis to test efficacy and safety in the most advanced cases.
Founding Underwriter for Development: Safety and Performance Validation (Human Test: Healthy Subjects)
Enables clinical testing of the polymer in healthy human subjects to verify safety and function.
Founding Underwriter for Development: Safety and Performance Validation (Human Test: People with Early Stages 1-3 CKD)
Supports human trials in early-stage chronic kidney disease patients to assess safety and performance across the disease spectrum.
Founding Underwriter for Development: Safety, Toxicology and Tolerability (In Vivo)
Funds nonclinical in vivo studies conducted under Good Laboratory Practice (GLP) regulations to validate safety and tolerability.
activities · 2 groups
What they do
-
Kidney Disease Education and Advocacy 3 activities
- Advocating for innovation in cardiovascular and renal healthSupports advocacy efforts and promotes bold thinking to challenge existing assumptions and improve prevention, treatment, and care models for cardiovascular and kidney diseases.
- Conducting research on polymer-based alternatives to dialysisConducts research and development of a daily oral capsule using polymer science as a non-invasive, over-the-counter alternative to traditional dialysis, including bench testing, in vivo validation, and human clinical trials across stages of chronic kidney disease and end-stage renal disease.
- Providing educational resources on cardio-renal health and preventionOffers evidence-based educational content on modifiable risk factors, lifestyle changes, and advances in cardio-renal care to improve patient understanding and support informed health decisions.
-
-
Medical Research Funding 1 activity
- Funding research in polymer science for cardio-renal treatmentsProvides financial support for research initiatives using polymer science to develop new treatments and technologies for cardiovascular and renal conditions, particularly those underfunded by traditional systems.
-
financials · form 990 · fy2025
revenue
Total revenue$6K
Contributions & grants$6K100%
Program service revenue$00%
Investment income$00%
Other revenue$0
expenses
Total expenses$2K
Program expenses0%
Admin / overhead41%
Fundraising59%
Salaries & benefits$0
Grants paid out$0
Largest expense lineFacilities
balance sheet
Total assets$4K
Cash$4K
Investments$0
Liabilities$0
Net assets$4K
Liquid reserves17.8 mo
1 years on record · 2025–2025
leadership · form 990 part vii · fy2025
Who runs it
board members · 3
- Arlette Eijpe — Director
- Danielle Berger — CFO
- Kenny Gorgas — CEO
relationships · 7
Who they work with
- Cardio Renal Foundation Network — Primary organization advancing innovations in cardio renal health through research and donor engagement.
- Cardio Renal Foundation Network — Primary organization advancing research in cardio renal care through polymer science.
- PayPal Giving Fund Partner — Processes tax-deductible donations and forwards them to Cardio Renal Foundation as recommended grants.
- Sponsors Partner — Organizations or entities that provide financial support to fund innovations in cardio renal health.
- Sponsors of the Cardio Renal Foundation Funder — Provide financial support to advance innovations in cardio renal health.
- Sponsors of the Cardio Renal Foundation Partner — Organizations or entities that provide funding to support innovations in cardio-renal health.
- corporate sponsors Partner — Corporate sponsors provide vital support for the foundation's work in cardiovascular and kidney health.
strategies · 4
How they approach the work
Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.
- Challenge-Driven Innovation Modelmethodology: bold_innovationBy challenging established practices and assumptions in cardio-renal care, the organization advances treatment options, because unconventional and independent thinking enables breakthroughs not possible within traditional frameworks.
- Education as Preventive Empowermentmethodology: education-as-preventionBy providing accessible education on cardio-renal care, the organization improves health outcomes, because informed individuals are better equipped to adopt preventive strategies and manage their conditions.
- Next-Generation Replacement Therapy Developmentmethodology: replacement-therapy-developmentBy developing a non-invasive, over-the-counter polymer-based alternative to dialysis, the organization aims to transform cardio-renal care, because replacing complex, clinic-dependent treatments with accessible therapies increases patient autonomy and scalability.
- Polymer-Science-Based Therapeutic Innovationmethodology: polymer-science-therapyBy applying polymer science to develop new treatments, the organization aims to replace or improve upon existing therapies for heart and kidney disease, because this approach enables safer, less burdensome, and non-invasive alternatives to dialysis and transplant.